In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Spasmomen Drug Master File in Korea (Spasmomen KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Spasmomen. The MFDS reviews the Spasmomen KDMF as part of the drug registration process and uses the information provided in the Spasmomen KDMF to evaluate the safety and efficacy of the drug.
After submitting a Spasmomen KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Spasmomen API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Spasmomen suppliers with KDMF on PharmaCompass.